Option Care Health (OPCH)
(Delayed Data from NSDQ)
$27.52 USD
+0.54 (2.00%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $27.54 +0.02 (0.07%) 5:36 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$27.52 USD
+0.54 (2.00%)
Updated Jul 10, 2024 04:00 PM ET
After-Market: $27.54 +0.02 (0.07%) 5:36 PM ET
3-Hold of 5 3
B Value C Growth A Momentum B VGM
Zacks News
Best Growth Stocks to Buy for August 23rd
by Zacks Equity Research
OPCH, STRL and FC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 23, 2023.
Best Growth Stocks to Buy for August 21st
by Zacks Equity Research
OPCH, TEX and FC made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 21, 2023.
Best Growth Stocks to Buy for August 18th
by Zacks Equity Research
FOUR, PCRFY and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 18, 2023.
Best Growth Stocks to Buy for August 17th
by Zacks Equity Research
GO, OPCH and NJDCY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 17, 2023.
OPCH vs. CHE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
OPCH vs. CHE: Which Stock Is the Better Value Option?
Best Growth Stocks to Buy for August 15th
by Zacks Equity Research
STRL, OPCH and NJDCY made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 15, 2023.
Best Growth Stocks to Buy for August 11th
by Zacks Equity Research
OPCH, PCRFY and BEKE made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 11, 2023.
Why Option Care (OPCH) Might be Well Poised for a Surge
by Zacks Equity Research
Option Care (OPCH) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Best Growth Stocks to Buy for August 4th
by Zacks Equity Research
TOL, CWCO and OPCH made it to the Zacks Rank #1 (Strong Buy) growth stocks list on August 4, 2023.
Zacks.com featured highlights include Mr. Cooper Group, Masco, Option Care Health, Solaris Oilfield Infrastructure, PulteGroup
by Zacks Equity Research
Mr. Cooper Group, Masco, Option Care Health, Solaris Oilfield Infrastructure, PulteGroup are part of the Zacks Screen of the Week article.
Time to Add These 5 Relative Price Strength Stocks
by Nilanjan Choudhury
COOP, MAS, OPCH, SOI and PHM are five stocks with explosive relative price strength.
Option Care (OPCH) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 186.36% and 0.39%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?
OPCH or USPH: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
OPCH vs. USPH: Which Stock Is the Better Value Option?
Here's Why Momentum in Option Care (OPCH) Should Keep going
by Zacks Equity Research
Option Care (OPCH) could be a great choice for investors looking to make a profit from fundamentally strong stocks that are currently on the move. It is one of the several stocks that made it through our "Recent Price Strength" screen.
Option Care (OPCH) Moves 5.2% Higher: Will This Strength Last?
by Zacks Equity Research
Option Care (OPCH) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.
Option Care (OPCH) Surges 6.3%: Is This an Indication of Further Gains?
by Zacks Equity Research
Option Care (OPCH) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.
Option Care (OPCH) Q1 Earnings and Revenues Top Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 23.53% and 1.99%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Amedisys (AMED) Q1 Earnings Top Estimates
by Zacks Equity Research
Amedisys (AMED) delivered earnings and revenue surprises of 16.28% and 0.58%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate ATI Physical Therapy, Inc. (ATIP) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
ATI Physical Therapy, Inc. (ATIP) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Option Care (OPCH) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Option Care (OPCH) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Universal Health (UHS) to Release Q1 Earnings: Factors to Note
by Zacks Equity Research
Universal Health's (UHS) Q1 results are likely to benefit from higher patient volumes and solid demand for behavioral healthcare services. However, increased labor costs might partly offset the results.
Option Care (OPCH) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Option Care (OPCH) delivered earnings and revenue surprises of 18.18% and 0.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Elanco Animal Health Incorporated (ELAN) Surpasses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Elanco Animal Health Incorporated (ELAN) delivered earnings and revenue surprises of 46.15% and 0.77%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Zacks Industry Outlook Highlights Option Care Health, LifeStance Health, Addus HomeCare and Pennant
by Zacks Equity Research
Option Care Health, LifeStance Health, Addus HomeCare and Pennant have been highlighted in this Industry Outlook article.
4 Stocks to Watch Amid a Challenging Outpatient Home Health Industry
by Zacks Equity Research
Despite the macroeconomic challenges, rising dependence on telehealth and the dominance of AI are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. OPCH, LFST, ADUS and PNTG are well poised to gain from the prospects.